 | • レポートコード：GIR-107A14045 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍液体生検のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍液体生検の種類別市場規模（ctDNA、CTC）、用途別市場規模（臨床検査室、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍液体生検の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Bio-Rad Laboratories、F. Hoffmann-La Roche、Illumina、QIAGEN N.V.、Thermo Fisher Scientific、Amoy Diagnostics、HaploX、Whole Genome Sequencing、Burning Rock Biotech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ctDNA、CTC ・用途別分析2016年-2026年：臨床検査室、病院 ・腫瘍液体生検の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍液体生検のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍液体生検のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍液体生検の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍液体生検の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Liquid Tumor Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Liquid Tumor Biopsy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Liquid Tumor Biopsy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Liquid Tumor Biopsy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ctDNA
CTC
Market segment by Application, can be divided into
Clinical Laboratories
Hospital
Market segment by players, this report covers
Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann-La Roche
Illumina
QIAGEN N.V.
Thermo Fisher Scientific
Amoy Diagnostics
HaploX
Whole Genome Sequencing
Burning Rock Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Liquid Tumor Biopsy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Liquid Tumor Biopsy, with revenue, gross margin and global market share of Liquid Tumor Biopsy from 2019 to 2021.
Chapter 3, the Liquid Tumor Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Liquid Tumor Biopsy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Liquid Tumor Biopsy research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Liquid Tumor Biopsy
1.2 Classification of Liquid Tumor Biopsy by Type
1.2.1 Overview: Global Liquid Tumor Biopsy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Liquid Tumor Biopsy Revenue Market Share by Type in 2020
1.2.3 ctDNA
1.2.4 CTC
1.3 Global Liquid Tumor Biopsy Market by Application
1.3.1 Overview: Global Liquid Tumor Biopsy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinical Laboratories
1.3.3 Hospital
1.4 Global Liquid Tumor Biopsy Market Size & Forecast
1.5 Global Liquid Tumor Biopsy Market Size and Forecast by Region
1.5.1 Global Liquid Tumor Biopsy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Liquid Tumor Biopsy Market Size by Region, (2016-2021)
1.5.3 North America Liquid Tumor Biopsy Market Size and Prospect (2016-2026)
1.5.4 Europe Liquid Tumor Biopsy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Liquid Tumor Biopsy Market Size and Prospect (2016-2026)
1.5.6 South America Liquid Tumor Biopsy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Liquid Tumor Biopsy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Liquid Tumor Biopsy Market Drivers
1.6.2 Liquid Tumor Biopsy Market Restraints
1.6.3 Liquid Tumor Biopsy Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Liquid Tumor Biopsy Product and Solutions
2.1.4 Abbott Laboratories Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Product and Solutions
2.2.4 Bio-Rad Laboratories Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business
2.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Product and Solutions
2.3.4 F. Hoffmann-La Roche Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Liquid Tumor Biopsy Product and Solutions
2.4.4 Illumina Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Illumina Recent Developments and Future Plans
2.5 QIAGEN N.V.
2.5.1 QIAGEN N.V. Details
2.5.2 QIAGEN N.V. Major Business
2.5.3 QIAGEN N.V. Liquid Tumor Biopsy Product and Solutions
2.5.4 QIAGEN N.V. Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 QIAGEN N.V. Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Product and Solutions
2.6.4 Thermo Fisher Scientific Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Amoy Diagnostics
2.7.1 Amoy Diagnostics Details
2.7.2 Amoy Diagnostics Major Business
2.7.3 Amoy Diagnostics Liquid Tumor Biopsy Product and Solutions
2.7.4 Amoy Diagnostics Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Amoy Diagnostics Recent Developments and Future Plans
2.8 HaploX
2.8.1 HaploX Details
2.8.2 HaploX Major Business
2.8.3 HaploX Liquid Tumor Biopsy Product and Solutions
2.8.4 HaploX Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 HaploX Recent Developments and Future Plans
2.9 Whole Genome Sequencing
2.9.1 Whole Genome Sequencing Details
2.9.2 Whole Genome Sequencing Major Business
2.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Product and Solutions
2.9.4 Whole Genome Sequencing Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Whole Genome Sequencing Recent Developments and Future Plans
2.10 Burning Rock Biotech
2.10.1 Burning Rock Biotech Details
2.10.2 Burning Rock Biotech Major Business
2.10.3 Burning Rock Biotech Liquid Tumor Biopsy Product and Solutions
2.10.4 Burning Rock Biotech Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Burning Rock Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Liquid Tumor Biopsy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Liquid Tumor Biopsy Players Market Share
3.2.2 Top 10 Liquid Tumor Biopsy Players Market Share
3.2.3 Market Competition Trend
3.3 Liquid Tumor Biopsy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Liquid Tumor Biopsy Revenue and Market Share by Type (2016-2021)
4.2 Global Liquid Tumor Biopsy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Liquid Tumor Biopsy Revenue Market Share by Application (2016-2021)
5.2 Liquid Tumor Biopsy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Liquid Tumor Biopsy Revenue by Type (2016-2026)
6.2 North America Liquid Tumor Biopsy Revenue by Application (2016-2026)
6.3 North America Liquid Tumor Biopsy Market Size by Country
6.3.1 North America Liquid Tumor Biopsy Revenue by Country (2016-2026)
6.3.2 United States Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
6.3.3 Canada Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
6.3.4 Mexico Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Liquid Tumor Biopsy Revenue by Type (2016-2026)
7.2 Europe Liquid Tumor Biopsy Revenue by Application (2016-2026)
7.3 Europe Liquid Tumor Biopsy Market Size by Country
7.3.1 Europe Liquid Tumor Biopsy Revenue by Country (2016-2026)
7.3.2 Germany Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
7.3.3 France Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
7.3.5 Russia Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
7.3.6 Italy Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Liquid Tumor Biopsy Revenue by Type (2016-2026)
8.2 Asia-Pacific Liquid Tumor Biopsy Revenue by Application (2016-2026)
8.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Region
8.3.1 Asia-Pacific Liquid Tumor Biopsy Revenue by Region (2016-2026)
8.3.2 China Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
8.3.3 Japan Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
8.3.4 South Korea Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
8.3.5 India Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
8.3.7 Australia Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Liquid Tumor Biopsy Revenue by Type (2016-2026)
9.2 South America Liquid Tumor Biopsy Revenue by Application (2016-2026)
9.3 South America Liquid Tumor Biopsy Market Size by Country
9.3.1 South America Liquid Tumor Biopsy Revenue by Country (2016-2026)
9.3.2 Brazil Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
9.3.3 Argentina Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Liquid Tumor Biopsy Revenue by Type (2016-2026)
10.2 Middle East & Africa Liquid Tumor Biopsy Revenue by Application (2016-2026)
10.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Country
10.3.1 Middle East & Africa Liquid Tumor Biopsy Revenue by Country (2016-2026)
10.3.2 Turkey Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
10.3.4 UAE Liquid Tumor Biopsy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Liquid Tumor Biopsy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Liquid Tumor Biopsy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Liquid Tumor Biopsy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Liquid Tumor Biopsy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Liquid Tumor Biopsy Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Liquid Tumor Biopsy Product and Solutions
Table 9. Abbott Laboratories Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Major Business
Table 12. Bio-Rad Laboratories Liquid Tumor Biopsy Product and Solutions
Table 13. Bio-Rad Laboratories Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 15. F. Hoffmann-La Roche Major Business
Table 16. F. Hoffmann-La Roche Liquid Tumor Biopsy Product and Solutions
Table 17. F. Hoffmann-La Roche Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Illumina Corporate Information, Head Office, and Major Competitors
Table 19. Illumina Major Business
Table 20. Illumina Liquid Tumor Biopsy Product and Solutions
Table 21. Illumina Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. QIAGEN N.V. Corporate Information, Head Office, and Major Competitors
Table 23. QIAGEN N.V. Major Business
Table 24. QIAGEN N.V. Liquid Tumor Biopsy Product and Solutions
Table 25. QIAGEN N.V. Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 27. Thermo Fisher Scientific Major Business
Table 28. Thermo Fisher Scientific Liquid Tumor Biopsy Product and Solutions
Table 29. Thermo Fisher Scientific Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Amoy Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Amoy Diagnostics Major Business
Table 32. Amoy Diagnostics Liquid Tumor Biopsy Product and Solutions
Table 33. Amoy Diagnostics Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. HaploX Corporate Information, Head Office, and Major Competitors
Table 35. HaploX Major Business
Table 36. HaploX Liquid Tumor Biopsy Product and Solutions
Table 37. HaploX Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Whole Genome Sequencing Corporate Information, Head Office, and Major Competitors
Table 39. Whole Genome Sequencing Major Business
Table 40. Whole Genome Sequencing Liquid Tumor Biopsy Product and Solutions
Table 41. Whole Genome Sequencing Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Burning Rock Biotech Corporate Information, Head Office, and Major Competitors
Table 43. Burning Rock Biotech Major Business
Table 44. Burning Rock Biotech Liquid Tumor Biopsy Product and Solutions
Table 45. Burning Rock Biotech Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Liquid Tumor Biopsy Revenue (USD Million) by Players (2019-2021)
Table 47. Global Liquid Tumor Biopsy Revenue Share by Players (2019-2021)
Table 48. Breakdown of Liquid Tumor Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Liquid Tumor Biopsy Players Head Office, Products and Services Provided
Table 50. Liquid Tumor Biopsy Mergers & Acquisitions in the Past Five Years
Table 51. Liquid Tumor Biopsy New Entrants and Expansion Plans
Table 52. Global Liquid Tumor Biopsy Revenue (USD Million) by Type (2016-2021)
Table 53. Global Liquid Tumor Biopsy Revenue Share by Type (2016-2021)
Table 54. Global Liquid Tumor Biopsy Revenue Forecast by Type (2021-2026)
Table 55. Global Liquid Tumor Biopsy Revenue by Application (2016-2021)
Table 56. Global Liquid Tumor Biopsy Revenue Forecast by Application (2021-2026)
Table 57. North America Liquid Tumor Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Liquid Tumor Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Liquid Tumor Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Liquid Tumor Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Liquid Tumor Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Liquid Tumor Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Liquid Tumor Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Liquid Tumor Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Liquid Tumor Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Liquid Tumor Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Liquid Tumor Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Liquid Tumor Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Liquid Tumor Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Liquid Tumor Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Liquid Tumor Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Liquid Tumor Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Liquid Tumor Biopsy Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Liquid Tumor Biopsy Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Liquid Tumor Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Liquid Tumor Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Liquid Tumor Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Liquid Tumor Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Liquid Tumor Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Liquid Tumor Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Liquid Tumor Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Liquid Tumor Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Liquid Tumor Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Liquid Tumor Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Liquid Tumor Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Liquid Tumor Biopsy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Liquid Tumor Biopsy Picture
Figure 2. Global Liquid Tumor Biopsy Revenue Market Share by Type in 2020
Figure 3. ctDNA
Figure 4. CTC
Figure 5. Liquid Tumor Biopsy Revenue Market Share by Application in 2020
Figure 6. Clinical Laboratories Picture
Figure 7. Hospital Picture
Figure 8. Global Liquid Tumor Biopsy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Liquid Tumor Biopsy Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Liquid Tumor Biopsy Revenue Market Share by Region (2016-2026)
Figure 11. Global Liquid Tumor Biopsy Revenue Market Share by Region in 2020
Figure 12. North America Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Liquid Tumor Biopsy Market Drivers
Figure 18. Liquid Tumor Biopsy Market Restraints
Figure 19. Liquid Tumor Biopsy Market Trends
Figure 20. Abbott Laboratories Recent Developments and Future Plans
Figure 21. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 22. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 23. Illumina Recent Developments and Future Plans
Figure 24. QIAGEN N.V. Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 26. Amoy Diagnostics Recent Developments and Future Plans
Figure 27. HaploX Recent Developments and Future Plans
Figure 28. Whole Genome Sequencing Recent Developments and Future Plans
Figure 29. Burning Rock Biotech Recent Developments and Future Plans
Figure 30. Global Liquid Tumor Biopsy Revenue Share by Players in 2020
Figure 31. Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Liquid Tumor Biopsy Revenue Market Share in 2020
Figure 33. Global Top 10 Players Liquid Tumor Biopsy Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Liquid Tumor Biopsy Revenue Share by Type in 2020
Figure 36. Global Liquid Tumor Biopsy Market Share Forecast by Type (2021-2026)
Figure 37. Global Liquid Tumor Biopsy Revenue Share by Application in 2020
Figure 38. Global Liquid Tumor Biopsy Market Share Forecast by Application (2021-2026)
Figure 39. North America Liquid Tumor Biopsy Sales Market Share by Type (2016-2026)
Figure 40. North America Liquid Tumor Biopsy Sales Market Share by Application (2016-2026)
Figure 41. North America Liquid Tumor Biopsy Revenue Market Share by Country (2016-2026)
Figure 42. United States Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Liquid Tumor Biopsy Sales Market Share by Type (2016-2026)
Figure 46. Europe Liquid Tumor Biopsy Sales Market Share by Application (2016-2026)
Figure 47. Europe Liquid Tumor Biopsy Revenue Market Share by Country (2016-2026)
Figure 48. Germany Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Liquid Tumor Biopsy Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Liquid Tumor Biopsy Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Liquid Tumor Biopsy Revenue Market Share by Region (2016-2026)
Figure 56. China Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Liquid Tumor Biopsy Sales Market Share by Type (2016-2026)
Figure 63. South America Liquid Tumor Biopsy Sales Market Share by Application (2016-2026)
Figure 64. South America Liquid Tumor Biopsy Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Liquid Tumor Biopsy Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Liquid Tumor Biopsy Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Liquid Tumor Biopsy Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Liquid Tumor Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の胆管腫瘍市場 2021：企業別、地域別、種類・用途別 The Biliary Tumor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…- 世界の腫瘍特異的抗原市場 2021：企業別、地域別、種類・用途別 The Tumor-Specific Antigen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の動物用皮膚生検パンチ市場 2021：企業別、地域別、種類・用途別 The Veterinary Skin Biopsy Punches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の腫瘍検出キット市場 2021：企業別、地域別、種類・用途別 The Tumor Detection Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の皮膚生検用パンチ市場 2021：企業別、地域別、種類・用途別 The Skin Biopsy Punches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…